Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors

(2016) Mohamed Shanavas et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group

(2015) N M Kröger et al.   LEUKEMIA

Donor lymphocyte infusions and second transplantation as salvage treatment for relapsed myelofibrosis after reduced-intensity allografting

(2012) Evgeny Klyuchnikov et al.   BRITISH JOURNAL OF HAEMATOLOGY

Allogeneic Stem Cell Transplantation for Myelofibrosis in 2012

(2012) Donal P. McLornan et al.   BRITISH JOURNAL OF HAEMATOLOGY

Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

(2009) N. Kroger et al.   BLOOD

JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation

(2009) N. Kroger et al.   BLOOD